Last updated on December 2010

Management of Patients With Alpha-1 Antitrypsin Deficiency Associated Emphysema

Brief description of study

The aim of this study is to describe the natural history of patients with alpha-1 antitrypsin associated emphysema and to figure out associated prognostic factors.

Detailed Study Description

All patients who suffer from this disease are followed every 6 months during a 5 years period. FEV1 decline is the primary endpoint. Quality of life assessed using the Saint George's Respiratory Questionary is recorded too.

Clinical Study Identifier: NCT00700934

Contact Investigators or Research Sites near you

Start Over

Gabriel Thabut, MD

Departement d' pid miologie, H pital Bichat
Paris, France
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.